Friday, June 23, 2023 3:38:34 PM
That's exactly right ..
Combo was stopped 5-6 days before , including tocilizumab 4 days before , and patient was more severe daily , to a physician it mean , patients didn't respond to this drugs,
At this time drugs as a rule are change ..in ANY medical situation ...
He was in severe immune stage of Covid , there was no response to ANYTHING else , only leronlimab
And he was not alone..
Former president of Philippines was treated with everything including tocilizumab , remdesivir ,steroids , He had no response to it , They put him on a ventilator , 5 days on a ventilator he received leronlimab , and 35 hrs later he was off the ventilator.
Those are VERY clear pictures ..
And patient in England after all those drugs was put on ECMO , About 70 days on ECMO he received leronlimab and in few days he was removed from ECMO.
Doctors treating many severe Covid patients , using leronlimab , like Dr Yang , have many stories like that.
We remember one of his patients Samantha M , and he treated over 30 patients like that.
GLTA longs.
Combo was stopped 5-6 days before , including tocilizumab 4 days before , and patient was more severe daily , to a physician it mean , patients didn't respond to this drugs,
At this time drugs as a rule are change ..in ANY medical situation ...
He was in severe immune stage of Covid , there was no response to ANYTHING else , only leronlimab
And he was not alone..
Former president of Philippines was treated with everything including tocilizumab , remdesivir ,steroids , He had no response to it , They put him on a ventilator , 5 days on a ventilator he received leronlimab , and 35 hrs later he was off the ventilator.
Those are VERY clear pictures ..
And patient in England after all those drugs was put on ECMO , About 70 days on ECMO he received leronlimab and in few days he was removed from ECMO.
Doctors treating many severe Covid patients , using leronlimab , like Dr Yang , have many stories like that.
We remember one of his patients Samantha M , and he treated over 30 patients like that.
GLTA longs.
Bullish
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
